A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association.
暂无分享,去创建一个
F. Christiansen | D. Middleton | C. Hurley | J. Hegland | D. Kukuruga | M. Oudshoorn | C. Raffoux | C. Brautbar | C. Navarrete | J. Wade | E. Ren | I. Andersen | S. Cleaver
[1] P Parham,et al. HLA class I region sequences, 1998. , 2008, Tissue antigens.
[2] S G Marsh,et al. HLA class II region sequences, 1998. , 2008, Tissue antigens.
[3] J. Adamson,et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. , 1998, The New England journal of medicine.
[4] Takato O. Yoshida,et al. EFFECT OF MATCHING OF CLASS I HLA ALLELES ON CLINICAL OUTCOME AFTER TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS FROM AN UNRELATED DONOR , 1998 .
[5] C Anasetti,et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. , 1998, The New England journal of medicine.
[6] G. Sirchia,et al. Comparison of serological and molecular typing for HLA-A and -B on cord blood lymphocytes. , 1998, Tissue antigens.
[7] R. Willemze,et al. Problems and possible solutions in finding an unrelated bone marrow donor. Results of consecutive searches for 240 Dutch patients , 1997, Bone Marrow Transplantation.
[8] K. Boucher,et al. HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. , 1997, Transplantation.
[9] C. Hurley,et al. Analysis of HLA-A and -B serologic typing of bone marrow registry donors using polymerase chain reaction with sequence-specific oligonucleotide probes and DNA sequencing. , 1997, Tissue antigens.
[10] D. Middleton,et al. HLA class I DNA typing of 215 "HLA-A, -B, -DR zero mismatched" kidney transplants. , 1997, Tissue antigens.
[11] D. Watkins,et al. A 25% error rate in serologic typing of HLA-B homozygotes. , 1997, Tissue antigens.
[12] D. Middleton,et al. The search for HLA-matched donors: a summary of HLA-A*, -B*, -DRB1/3/4/5* alleles and their association with serologically defined HLA-A, -B, -DR antigens. , 1997, Tissue antigens.
[13] J. Russell,et al. Error rate for HLA-B antigen assignment by serology: implications for proficiency testing and utilization of DNA-based typing methods. , 1997, Tissue antigens.
[14] J. Hegland,et al. Accurate typing of HLA-A antigens and analysis of serological deficiencies. , 1997, Tissue antigens.
[15] P. Parham. Filling in the blanks. , 1997, Tissue antigens.
[16] D. Woodfield,et al. Donor work-up and transport of bone marrow – recommendations and requirements for a standardized practice throughout the world from the Donor Registries and Quality Assurance Working Groups of the World Marrow Donor Association (WMDA) , 1997, Bone Marrow Transplantation.
[17] C. Chastang,et al. Outcome of cord-blood transplantation from related and unrelated donors , 1997 .
[18] C K Hurley,et al. HLA-B alleles associated with the B15 serologically defined antigens. , 1997, Human immunology.
[19] M. Labopin,et al. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching , 1997, Bone Marrow Transplantation.
[20] A. Little,et al. Factors influencing the outcome of bone marrow transplants using unrelated donors , 1997, Immunological reviews.
[21] J. Hansen,et al. Hematopoietic stem cell transplants from unrelated donors , 1997, Immunological reviews.
[22] E. Goulmy. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy , 1997, Immunological reviews.
[23] J P Klein,et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] C. Hurley. Acquisition and use of DNA-based HLA typing data in bone marrow registries. , 1997, Tissue antigens.
[25] A. Cambon-Thomsen,et al. Review article Microsatellites in the HLA region: an overview , 1997 .
[26] D. Middleton,et al. Application of an HLA-B PCR-SSOP typing method to a bone marrow donor registry , 1997, Bone Marrow Transplantation.
[27] D. Middleton,et al. Development of PCR-SSOP for HLA-A typing of bone marrow registry donors. , 1997, Tissue antigens.
[28] M. Oudshoorn,et al. HLA gene haplotype frequencies in bone marrow donors worldwide registries. , 1997, Human immunology.
[29] G. Longton,et al. Definition of HLA-DQ as a transplantation antigen. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Carrington,et al. Selection of transplant donors based on MHC microsatellite data. , 1996, Human immunology.
[31] J. Madrigal,et al. A novel method for simultaneous high resolution identification of HLA-A, HLA-B, and HLA-Cw alleles. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[32] H. Noreen,et al. Lack of correlation of MLC reactivity with acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation. , 1996, Human immunology.
[33] J. Kurtzberg,et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. , 1996, The New England journal of medicine.
[34] J. A. Hansen. Development of registries of HLA-typed volunteer marrow donors. , 1996, Tissue antigens.
[35] M. Oudshoorn,et al. Validation of large data sets, an essential prerequisite for data analysis: an analytical survey of the Bone Marrow Donors Worldwide. , 1996, Tissue antigens.
[36] H. V. van Houwelingen,et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. , 1996, The New England journal of medicine.
[37] B. Dupont,et al. Minor histocompatibility antigens and marrow transplantation. , 1996, The New England journal of medicine.
[38] D. Monos,et al. Large-scale DRB and DQB1 oligonucleotide typing for the NMDP registry: progress report from year 2. , 1996, Tissue antigens.
[39] J. A. Hansen. Inclusive donor search. , 1995, Tissue antigens.
[40] E. Milford,et al. Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor. , 1995 .
[41] C. Carcassi,et al. Updated characterization of the fourth ancestral haplotypes using Asia-Oceania Histocompatibility Workshop panel , 1995 .
[42] A. Cambon-Thomsen,et al. HLA ‐A,‐B,‐DR HAPLOTYPE FREQUENCIES IN FRANCE—IMPLICATIONS FOR RECRUITMENT OF POTENTIAL BONE MARROW DONORS , 1995, Transplantation.
[43] C. Witt,et al. IMMUNOGENETIC ANALYSIS OF SUCCESSFUL AND REJECTED BONE MARROW GRAFTS WITHIN ONE FAMILY * , 1994, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[44] Ruth Etzioni,et al. Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: matching for transplants from related haploidentical donors. , 1994, Tissue Antigens.
[45] R. Duquesnoy,et al. Progress report on the ASHI/CAP Proficiency Survey Program in Histocompatibility Testing. I. HLA-A,B,C typing, antibody screening, and lymphocytotoxicity crossmatching. American Society for Histocompatibility and Immunogenetics. College of American Pathologists. , 1994, Human immunology.
[46] R. Duquesnoy,et al. Progress report on the ASHI/CAP Proficiency Survey Program in Histocompatibility Testing. II. HLA-DR, DQ serologic typing, antibody identification, and B-cell crossmatching. American Society for Histocompatibility of Immunogenetics. College of American Pathologists. , 1994, Human immunology.
[47] J. Hansen,et al. The MLC assay as a test for HLA-D region compatibility between patients and unrelated donors: results of a national marrow donor program involving multiple centers. , 1993, Tissue antigens.
[48] D. Monos,et al. Large-scale oligonucleotide typing for HLA-DRB1/3/4 and HLA-DQB1 is highly accurate, specific, and reliable. , 1993, Tissue antigens.
[49] J. Falkenburg,et al. Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation. , 1993, Human immunology.
[50] I. Doxiadis,et al. Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant. , 1993, Human immunology.
[51] J. Gorski,et al. The predictive value of HLA-DR oligotyping for MLC responses. , 1992, Transplantation.
[52] B. Mach,et al. Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[53] H. Erlich,et al. Oligonucleotide typing is a perfect tool to identify antigens stimulatory in the mixed lymphocyte culture. , 1991, Human immunology.
[54] S. Yang,et al. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. , 1990, The New England journal of medicine.
[55] R. Storb,et al. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. , 1990, Human immunology.
[56] R. Truitt,et al. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. , 1990, The New England journal of medicine.